Cephalon News

Pharmaceutical company Cephalon, Inc. announced Wednesday that it has filed a suit in a Delaware District Court against Teva Pharmaceuticals USA, Inc.

Cephalon, Inc. today announced that it has filed a lawsuit in U.S. District Court in Delaware against Teva Pharmaceuticals USA, Inc.

Last week's top five stocks that ended close to their 52-week lows were Mizuho Financial Group Inc, Cephalon Inc, Emdeon Inc, American Public Education, and Whitney Holding Corp.

Dow Jones Reprints: This copy is for your personal, non-commerical use only. To order presentation-ready copies for distribution to your colleagues, clients or customers, use the Order Reprints tool on any article or visit www.djreprints.com Cephalon Shares of the biopharmaceuticals company slipped 8.6% on news of mixed results for reslizumab in ...

BUYINS.NET / www.squeezetrigger.com is monitoring the Seasonality of Qwest Communications , Bunge Limited , Cephalon , Dr.

Cephalon shares are falling today on disappointing results from a drug to treat pediatric eosinophilic esophagitis, an inflammation of the esophagus.

Main Category: GastroIntestinal / Gastroenterology Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 24 Nov 2009 - 1:00 PST Ception Therapeutics, Inc., a privately held biopharmaceutical company, and Cephalon, Inc.

Every day, the sun rises on Wall Street, and a plethora of professional analysts wake to issue new opinions on stocks.

Ception Therapeutics Inc. and Cephalon Inc. announced mixed results Monday for late-stage testing of Cinquil, an experimental drug the two suburban Philadelphia biotechnology companies are developing to treat pediatric eosinophilic esophagitis.

Tuesday, November 17, 2009 Money Talks Click charts to enlarge. Will the financials lead us higher or not? Here's the Financial SPDR ...there's an island gap , a recent symmetrical triangle, and a possible head-and-shoulders top .

Teva Pharmaceutical Industries Ltd. said Tuesday the Food and Drug Administration approved its generic version of the heartburn drug Prevacid.

Cephalon Inc. will give Barr Pharmaceuticals Inc. a license to sell a generic version of the pain drug Fentora in 2018 as part of a patent lawsuit settlement, according to a Securities and Exchange Commission filing Thursday.

Utility AES sees spate of call selling : The electric utility has been dead money for the last three months, and now one investor may be throwing in the towel.

A flex building in West Chester traded for $12 million, or more than $90 a square foot, in what is a strong showing for that type of building.

Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Pharma Industry / Biotech Industry Cephalon, Inc.

" November 5, 2009 - " Cephalon, Inc. today announced the journal Cancer has published a pivotal study demonstrating that TREANDAA for Injection induced durable responses in patients with indolent B-cell non-Hodgkin's lymphoma whose disease had progressed during or within six months of treatment with rituximab.

Alkermes Inc. filed Quarterly Report for the period ended 2009-09-30. Alkermes Inc.

Cephalon specializes in bio-pharmaceuticals that target central nervous system disorders, pain treatments, and oncology .

Cephalon, Inc. today announced that the November issue of Mayo Clinic Proceedings has published data from a pivotal Phase III trial demonstrating that NUVIGIL Tablets [C-IV] significantly improved wakefulness throughout the shift in patients with excessive sleepiness associated with shift work disorder .

If you think to invest in healthcare industry amid the government controlled reform, you may want to look at Edward Owens a TM Vanguard Healthcare Fund portfolio.